← Back to Search

Charge for Obesity

N/A

Waitlist Available

Led By Gary G Bennett, PhD

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

males and females aged 18-65 years

participants have English language proficiency

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 6 & 12 months

Awards & highlights

Study Summary

This trial will test different versions of a weight-loss app that uses text messaging. It will enroll 448 adults and follow them for 6 months, with a 6-month follow-up.

Eligible Conditions

Obesity
Weight Loss

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 6 & 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 6 & 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 & 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Weight

Secondary outcome measures

Change in categorical weight loss (> 5%) at 6-months

Change in diet

Change in physical activity

+3 more

Trial Design

32Treatment groups

Experimental Treatment

Group I: Arm 9: WT-EM-OR-SS-CSExperimental Treatment1 Intervention

Charge: weekly tracking, expert-generated motivational messages, one reminder, summary score, compare to self

Group II: Arm 8: WT-SM-MR-SF-CGExperimental Treatment1 Intervention

Charge: weekly tracking, self-generated motivational messages, multiple reminders, specific feedback, compare to group

Group III: Arm 7: WT-SM-MR-SF-CSExperimental Treatment1 Intervention

Charge: weekly tracking, self-generated motivational messages, multiple reminders, specific feedback, compare to self

Group IV: Arm 6: WT-SM-MR-SS-CGExperimental Treatment1 Intervention

Charge: weekly tracking, self-generated motivational messages, multiple reminders, summary score, compare to group.

Group V: Arm 5: WT-SM-MR-SS-CSExperimental Treatment1 Intervention

Charge: weekly tracking, self-generated motivational messages, multiple reminders, summary score, compare to self.

Group VI: Arm 4: WT-SM-OR-SF-CGExperimental Treatment1 Intervention

Charge: weekly tracking, self-generated motivational messages, one reminder, specific goal feedback, compare to group

Group VII: Arm 3: WT-SM-OR-SF-CSExperimental Treatment1 Intervention

Charge: weekly tracking, self-generated motivational messages, one reminder, specific goal feedback, compare to self

Group VIII: Arm 32: DT-EM-MR-GF-CGExperimental Treatment1 Intervention

Charge: daily tracking, expert-generated motivational messages, multiple reminders, specific goal feedback, compare to group.

Group IX: Arm 31: DT-EM-MR-GF-CSExperimental Treatment1 Intervention

Charge: daily tracking, expert-generated motivational messages, multiple reminders, specific goal feedback, compare to self

Group X: Arm 30: DT-EM-MR-SS-CGExperimental Treatment1 Intervention

Charge: daily tracking, expert-generated motivational messages, multiple reminders, summary score, compare to group

Group XI: Arm 2: WT-SM-OR-SS-CGExperimental Treatment1 Intervention

Charge: weekly tracking, self-generated motivational messages, one reminder, summary score, compare to group

Group XII: Arm 29: DT-EM-MR-SS-CSExperimental Treatment1 Intervention

Charge: daily tracking, expert-generated motivational messages, multiple reminders, summary score, compare to self

Group XIII: Arm 28: DT-EM-OR-SF-CGExperimental Treatment1 Intervention

Charge: daily tracking, expert-generated motivational messages, one reminder, specific goal feedback, compare to group

Group XIV: Arm 27: DT-EM-OR-SF-CSExperimental Treatment1 Intervention

Charge: daily tracking, expert-generated motivational messages, one reminder, specific goal feedback, compare to self

Group XV: Arm 26: DT-EM-OR-SS-CGExperimental Treatment1 Intervention

Charge: daily tracking, expert-generated motivational messages, one reminder, summary score, compare to group

Group XVI: Arm 25: DT-EM-OR-SS-CSExperimental Treatment1 Intervention

Charge: daily tracking, expert-generated motivational messages, one reminder, summary score, compare to self

Group XVII: Arm 24: DT-SM-MR-SF-CGExperimental Treatment1 Intervention

Charge: daily tracking, self-generated motivational messages, multiple reminders, specific goal feedback, compare to group

Group XVIII: Arm 23: DT-SM-MR-SF-CSExperimental Treatment1 Intervention

Charge: daily tracking, self-generated motivational messages, multiple reminders, specific goal feedback, compare to self.

Group XIX: Arm 22: DT-SM-MR-SS-CGExperimental Treatment1 Intervention

Charge: daily tracking, self-generated motivational messages, multiple reminders, summary score, compare to group.

Group XX: Arm 21: DT-SM-MR-SS-CSExperimental Treatment1 Intervention

Charge: daily tracking, self-generated motivational messages, multiple reminders, summary score, compare to self

Group XXI: Arm 20: DT-SM-OR-SF-CGExperimental Treatment1 Intervention

Charge: daily tracking, self-generated motivational messages, one reminder, specific goal feedback, compare to group

Group XXII: Arm 1: WT-SM-OR-SS-CSExperimental Treatment1 Intervention

Charge: weekly tracking, self-generated motivational messages, one reminder, summary score, compare to self

Group XXIII: Arm 19: DT-SM-OR-SF-CSExperimental Treatment1 Intervention

Charge: daily tracking, self-generated motivational messages, one reminder, specific goal feedback, compare to self.

Group XXIV: Arm 18: DT-SM-OR-SS-CGExperimental Treatment1 Intervention

Charge: daily tracking, self-generated motivational messages, one reminder, summary score, compare to group

Group XXV: Arm 17: DT-SM-OR-SS-CSExperimental Treatment1 Intervention

Charge: daily tracking, self-generated motivational messages, one reminder, summary score, compare to self.

Group XXVI: Arm 16: WT-EM-MR-SF-CGExperimental Treatment1 Intervention

Charge: weekly tracking, expert-generated motivational messages, multiple reminders, specific goal feedback, compare to group

Group XXVII: Arm 15: WT-EM-MR-SF-CSExperimental Treatment1 Intervention

Charge: weekly tracking, expert-generated motivational messages, multiple reminders, specific goal feedback, compare to self

Group XXVIII: Arm 14: WT-EM-MR-SS-CGExperimental Treatment1 Intervention

Charge: weekly tracking, expert-generated motivational messages, multiple reminders,summary score, compare to group

Group XXIX: Arm 13: WT-EM-MR-SS-CSExperimental Treatment1 Intervention

Charge: weekly tracking, expert-generated motivational messages, multiple reminders, summary score, compare to self

Group XXX: Arm 12: WT-EM-OR-SF-CGExperimental Treatment1 Intervention

Charge: weekly tracking, expert-generated motivational messages, one reminder, specific goal feedback, compare to group.

Group XXXI: Arm 11: WT-EM-OR-SF-CSExperimental Treatment1 Intervention

Charge: weekly tracking, expert-generated motivational messages, one reminder, specific goal feedback, compare to self

Group XXXII: Arm 10: WT-EM-OR-SS-CGExperimental Treatment1 Intervention

Charge: weekly tracking, expert-generated motivational messages, one reminder, summary score, compare to group

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Charge

2018

N/A

~540

0 / 5Eligibility criteria met

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor

2,356 Previous Clinical Trials

3,418,592 Total Patients Enrolled

80 Trials studying Obesity

31,159 Patients Enrolled for Obesity

Gary G Bennett, PhDPrincipal InvestigatorBishop-MacDermott Family Professor of Psychology, Global Health & Medicine

5 Previous Clinical Trials

982 Total Patients Enrolled

3 Trials studying Obesity

628 Patients Enrolled for Obesity

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there age restrictions for participation in the clinical trial?

"This medical study is restricted to those aged 18-65. There are 236 trials tailored for individuals below the age of consent and 714 studies committed to seniors over 65 years old."

Answered by AI

How can I become a participant in this research endeavor?

"Potential participants in this clinical trial must have experienced weight loss and be of legal age (18-65). This study is seeking a total enrolment of 448 individuals."

Answered by AI

Are there still slots available for participants in this clinical research?

"As per the details on clinicaltrials.gov, this specific medical trial is not currently seeking new patients. It was initially posted in January 2018 and last altered on March 21st 2022. Nevertheless, there are still 1134 other trials that need participants at present."

Answered by AI